ATE53583T1 - Beta-carbolin-3-carbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung. - Google Patents

Beta-carbolin-3-carbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung.

Info

Publication number
ATE53583T1
ATE53583T1 AT85105259T AT85105259T ATE53583T1 AT E53583 T1 ATE53583 T1 AT E53583T1 AT 85105259 T AT85105259 T AT 85105259T AT 85105259 T AT85105259 T AT 85105259T AT E53583 T1 ATE53583 T1 AT E53583T1
Authority
AT
Austria
Prior art keywords
carboline
beta
production
acid derivatives
carbonic acid
Prior art date
Application number
AT85105259T
Other languages
English (en)
Inventor
Erling Niels Petersen
Leif Helth Jensen
Frank Waetjen
Dieter Seidelmann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of ATE53583T1 publication Critical patent/ATE53583T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Organic Insulating Materials (AREA)
  • Lubricants (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT85105259T 1984-05-15 1985-04-30 Beta-carbolin-3-carbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung. ATE53583T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK2401/84A DK240184D0 (da) 1984-05-15 1984-05-15 Beta-carboline-3-carboxylic acid derivatives and method of preparing the same
EP85105259A EP0161575B1 (de) 1984-05-15 1985-04-30 Beta-Carbolin-3-carbonsäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
ATE53583T1 true ATE53583T1 (de) 1990-06-15

Family

ID=8112117

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85105259T ATE53583T1 (de) 1984-05-15 1985-04-30 Beta-carbolin-3-carbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung.

Country Status (14)

Country Link
US (2) US4631285A (de)
EP (1) EP0161575B1 (de)
JP (1) JPH089615B2 (de)
AT (1) ATE53583T1 (de)
AU (1) AU581435B2 (de)
CA (1) CA1264748A (de)
DE (1) DE3578178D1 (de)
DK (1) DK240184D0 (de)
ES (1) ES8603184A1 (de)
FI (1) FI83960C (de)
HU (1) HU200767B (de)
IE (1) IE58114B1 (de)
IL (1) IL75116A (de)
ZA (1) ZA853717B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ194747A (en) * 1979-08-29 1988-11-29 Schering Ag 9h-pyrido(3,4-b)indol-3-ylcarboxylic acid derivatives
FR2562071B1 (fr) * 1984-03-30 1986-12-19 Sanofi Sa Triazolo(4,3-b)pyridazines, procede pour leur preparation et compositions pharmaceutiques les contenant
DE3540653A1 (de) * 1985-11-13 1987-05-14 Schering Ag Neue 3-oxadiazol- und 3-carbonsaeure-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel
US4952584A (en) * 1986-01-11 1990-08-28 Beecham Group P.L.C. 9H-pyrido[2,B-8]indole-3-carboxylic acid ester compounds having useful pharmaceutical activity
DE3609699A1 (de) * 1986-03-20 1987-09-24 Schering Ag 5- oder 6-substituierte-(beta)-carbolin-3-carbonsaeureester
US4957915A (en) * 1989-02-27 1990-09-18 Biomeasure, Inc. Benzodiazepine analogs
JPH0717959B2 (ja) * 1989-03-30 1995-03-01 新日本製鐵株式会社 一方向性高磁束密度電磁鋼板の製造方法
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
CA2789097C (en) 2005-04-28 2017-02-21 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1084256A (de) * 1963-11-06
JPS52123180A (en) * 1976-04-09 1977-10-17 Hitachi Ltd High dielectric strength semiconductor device
JPS5643283A (en) * 1979-08-29 1981-04-21 Schering Ag Betaacarbolinee33carboxylic acid derivative* its manufacture and psychotic medicine containing it
NZ194747A (en) * 1979-08-29 1988-11-29 Schering Ag 9h-pyrido(3,4-b)indol-3-ylcarboxylic acid derivatives
AU544731B2 (en) * 1980-02-29 1985-06-13 Schering Aktiengesellschaft Beta-carbolin -3-carboxylic acid derivatives
JPS574987A (en) * 1980-06-09 1982-01-11 Sankyo Co Ltd Pyridoindolecarboxylic acid derivative and its preparation
JPS57123180A (en) * 1980-12-17 1982-07-31 Schering Ag 3-substituted beta-carboline, manufacture and psychotropic drug containing same
DE3240511A1 (de) * 1982-10-29 1984-05-03 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von ss-carbolinderivaten
DK149270C (da) * 1983-05-27 1986-08-25 Schering Ag Analogifremgangsmaade til fremstilling af beta-carbolin-3-carboxylsyrederivater
DE3335323A1 (de) * 1983-09-27 1985-04-04 Schering AG, 1000 Berlin und 4709 Bergkamen Substituierte ss-carboline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
FI83960B (fi) 1991-06-14
JPH089615B2 (ja) 1996-01-31
IE851204L (en) 1985-11-15
US4748180A (en) 1988-05-31
IL75116A0 (en) 1985-09-29
ZA853717B (en) 1986-01-29
CA1264748A (en) 1990-01-23
ES543154A0 (es) 1986-01-01
HUT37792A (en) 1986-02-28
FI83960C (fi) 1991-09-25
ES8603184A1 (es) 1986-01-01
US4631285A (en) 1986-12-23
HU200767B (en) 1990-08-28
EP0161575B1 (de) 1990-06-13
DK240184D0 (da) 1984-05-15
IE58114B1 (en) 1993-07-14
AU4241385A (en) 1985-11-21
FI851932L (fi) 1985-11-16
EP0161575A3 (en) 1987-03-25
FI851932A0 (fi) 1985-05-15
AU581435B2 (en) 1989-02-23
JPS6140284A (ja) 1986-02-26
IL75116A (en) 1989-10-31
DE3578178D1 (de) 1990-07-19
EP0161575A2 (de) 1985-11-21

Similar Documents

Publication Publication Date Title
ATE51622T1 (de) Beta-carbolin-3-oxadiazolylderivate, verfahren zu ihrer herstellung und ihre verwendung.
ATE176476T1 (de) Guanidinalkyl-1, 1-bisphosphonsäurederivate, verfahren zu ihrer herstellung und ihre verwendung
ATE53583T1 (de) Beta-carbolin-3-carbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung.
ATE211474T1 (de) Galanthamin derivate, verfahren zu ihrer herstellung und ihre verwendung als medikamente
ZA9410181B (en) Arylacetic acid derivatives.
DE3673468D1 (de) N-alkyl-2,6-dimethylmorpholinio-carbonsaeureamid-salze, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
ATE19058T1 (de) Substituierte hydroxymalonsaeurediamide, verfahren zu ihrer herstellung sowie ihre verwendung als schaedlingsbekaempfungsmittel.
ATE66209T1 (de) Dihydropyridinamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
ATE184003T1 (de) 4-iminochinoline, verfahren zu ihrer herstellung und ihre verwendung
DE3781383D1 (de) 2,2-dimethylcyclopropancarbonsaeurederivate, die eine gesaettigte halogenierte kette an c-3 tragen, verfahren und zwischenprodukte zu ihrer herstellung, ihre verwendung als pestizide und sie enthaltende zusammensetzungen.
ATE113598T1 (de) Substituierte vinylcephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3777464D1 (de) Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung.
ATE135693T1 (de) Halogeno-4-methylpyrazole und verfahren zu ihrer herstellung
DE68907857D1 (de) Beta-d-phenylthioxyloside, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE60599T1 (de) Chinolin-8-carbonsaeureazolide, ein verfahren zu ihrer herstellung und ihre verwendung als herbizide.
ATE5143T1 (de) Clavulansaeure-derivate und verfahren zu ihrer herstellung.
DE3669157D1 (de) Alpha-allylierte arylalkyltriazole, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
DE69428457D1 (de) 1,4-benzoxazin-2-essigsäureverbindung, verfahren zu ihrer herstellung und ihre verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee